4. CT findings show solitary or multiple nodules with cystic airspaces.
You may not be if
1. A history of previous or co-existing malignant tumors;
2. Systemic anti-tumor therapies, including chemotherapy, radiotherapy, or targeted therapies (such as monoclonal antibodies, small-molecule tyrosine kinase inhibitors, among others), were administered prior to enrollment;
3. Refusal to participate in the study.
Cohort 2: Multi-omics study of lung cancer associated with cystic airspaces
1. A history of previous or co-existing malignant tumors;
2. Systemic anti-tumor therapies, including chemotherapy, radiotherapy, or targeted therapies (such as monoclonal antibodies, small-molecule tyrosine kinase inhibitors, among others), were administered prior to enrollment;
3. Refusal to participate in the study.
Clareo Health | Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
